First experience using LMI1195 PET in patients with the suspicion of pheochromocytoma or paraganglioma

C Rischpler, A Schlitter, M Herz, B Yousefi… - 2018 - Soc Nuclear Med
51 Objectives: Pheochromocytoma (PHEO) or paraganglioma (PARA) are known to
overexpress the norepinephrine transporter (NET). NET can be imaged by PET using N-[3 …

Improved resolution and sensitivity of [18F]MFBG PET compared with [123I]MIBG SPECT in a patient with a norepinephrine transporter–expressing tumour

E Pauwels, S Celen, M Vandamme, W Leysen… - European Journal of …, 2021 - Springer
The most widely used radiopharmaceutical for molecular imaging targeting the
norepinephrine transporter in neuroendocrine tumours is meta-[123I] iodobenzylguanidine …

Malignant Pheochromocytoma Imaging with [124I]mIBG PET/MR

V Hartung-Knemeyer… - The Journal of …, 2012 - academic.oup.com
Pheochromocytoma localized in the adrenal medulla (in 85%) or in the thoracic/abdominal
sympathetic trunk (paraganglioma) has malignant potential in about 10% of cases …

Pheochromocytomas: Detection with 18F DOPA Whole-Body PET—Initial Results1

S Hoegerle, E Nitzsche, C Altehoefer, N Ghanem… - Radiology, 2002 - pubs.rsna.org
PURPOSE: To evaluate fluorine 18 (18F) dihydroxyphenylalanine (DOPA) whole-body
positron emission tomography (PET) as a biochemical imaging approach for detection of …

Diagnostic performance of 124I-metaiodobenzylguanidine PET/CT in patients with pheochromocytoma

M Weber, J Schmitz, I Maric, K Pabst… - Journal of Nuclear …, 2022 - Soc Nuclear Med
123/131I-metaiodobenzylguanidine (MIBG) scintigraphy has shown a high specificity for
imaging pheochromocytoma and paraganglioma, but with low sensitivity because of low …

Preclinical evaluation of 18F-LMI1195 for in vivo imaging of pheochromocytoma in the MENX tumor model

FC Gaertner, T Wiedemann, BH Yousefi… - Journal of Nuclear …, 2013 - Soc Nuclear Med
We evaluated 18F-LMI1195 (1-(3-bromo-4-(3-18F-fluoro-propoxy) benzyl) guanidine), a
metaiodobenzylguanidine (MIBG) analog, for the detection of pheochromocytoma in a …

Comparison of 6-18F-fluorodopamine PET with 123I-metaiodobenzylguanidine and 111in-pentetreotide scintigraphy in localization of nonmetastatic and metastatic …

I Ilias, CC Chen, JA Carrasquillo… - Journal of Nuclear …, 2008 - Soc Nuclear Med
We compared functional imaging modalities including PET with 6-18F-fluorodopamine (18F-
DA) with 123I-metaiodobenzylguanidine (123I-MIBG) and somatostatin receptor …

18F-FDOPA PET compared with 123I-metaiodobenzylguanidine scintigraphy and 18F-FDG PET in secreting sporadic pheochromocytoma

A Lugat, D Drui, E Mirallié… - Clinical Nuclear …, 2019 - journals.lww.com
We report the case of a 23-year-old man presenting a right hypersecreting
pheochromocytoma, falsely negative on 18 F-FDG PET/CT and on 123 I …

Diagnostic accuracy of 68Ga-DOTANOC PET/CT imaging in pheochromocytoma

P Sharma, VS Dhull, S Arora, P Gupta, R Kumar… - European journal of …, 2014 - Springer
Purpose The purpose of the present study was to evaluate the diagnostic accuracy of 68 Ga-
DOTANOC positron emission tomography (PET)/CT in patients with suspicion of …

[HTML][HTML] Comparison of 6-[18F]-fluorodopamine positron emission tomography to [123I]-metaiodobenzylguanidine and [111In]-pentetreotide scintigraphy in the …

I Ilias, CC Chen, JA Carrasquillo… - Journal of nuclear …, 2008 - ncbi.nlm.nih.gov
We compared functional imaging modalities including positron emission tomography (PET)
with 6-[18 F]-fluorodopamine ([18 F]-DA) against [123 I]-metaiodobenzylguanidine ([123 I] …